Insider Transactions in Q2 2022 at Eli Lilly & CO (LLY)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 28
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
900
-0.0%
|
$296,100
$329.01 P/Share
|
Jun 27
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
41,857
-0.04%
|
$13,770,953
$329.05 P/Share
|
Jun 24
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
215,000
-0.04%
|
$69,445,000
$323.95 P/Share
|
Jun 23
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
205,000
-0.04%
|
$63,755,000
$311.37 P/Share
|
Jun 22
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.04%
|
$64,470,000
$307.35 P/Share
|
Jun 21
2022
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+3.54%
|
$9,801
$297.34 P/Share
|
Jun 21
2022
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+39.29%
|
$9,801
$297.34 P/Share
|
Jun 21
2022
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+2.53%
|
$9,801
$297.34 P/Share
|
Jun 21
2022
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.34%
|
$13,959
$297.34 P/Share
|
Jun 21
2022
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
38
+0.07%
|
$11,286
$297.34 P/Share
|
Jun 21
2022
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+0.05%
|
$9,801
$297.34 P/Share
|
Jun 01
2022
|
Diogo Rau EVP & CIDO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,166
-41.88%
|
$990,958
$313.44 P/Share
|
Jun 01
2022
|
Diogo Rau EVP & CIDO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,560
+50.0%
|
-
|
Jun 01
2022
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
1,000
-13.75%
|
$313,000
$313.44 P/Share
|
May 27
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
200,000
-0.02%
|
$63,600,000
$318.86 P/Share
|
May 26
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
178,390
-0.03%
|
$55,479,290
$311.04 P/Share
|
May 25
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
41,610
-0.01%
|
$12,857,490
$309.36 P/Share
|
May 24
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
100,000
-0.05%
|
$30,600,000
$306.01 P/Share
|
May 23
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
118,856
-0.04%
|
$36,013,368
$303.37 P/Share
|
May 18
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
700
-0.0%
|
$211,400
$302.0 P/Share
|
May 17
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
19,683
-0.01%
|
$5,944,266
$302.73 P/Share
|
May 16
2022
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+0.05%
|
$9,867
$299.38 P/Share
|
May 16
2022
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.34%
|
$14,053
$299.38 P/Share
|
May 16
2022
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+3.68%
|
$9,867
$299.38 P/Share
|
May 16
2022
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+50.0%
|
$5,382
$299.38 P/Share
|
May 16
2022
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
32
+2.53%
|
$9,568
$299.38 P/Share
|
May 16
2022
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
38
+0.07%
|
$11,362
$299.38 P/Share
|
May 16
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
80,761
-0.04%
|
$24,389,822
$302.75 P/Share
|
Apr 18
2022
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
38
+0.07%
|
$11,324
$298.82 P/Share
|
Apr 18
2022
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+0.05%
|
$9,834
$298.82 P/Share
|
Apr 18
2022
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
32
+2.59%
|
$9,536
$298.82 P/Share
|
Apr 18
2022
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
42
+0.31%
|
$12,516
$298.82 P/Share
|
Apr 18
2022
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
33
+3.82%
|
$9,834
$298.82 P/Share
|
Apr 08
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
139,045
-0.03%
|
$43,103,950
$310.88 P/Share
|
Apr 07
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
70,955
-0.02%
|
$21,996,050
$310.32 P/Share
|
Apr 06
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
51,851
-0.0%
|
$15,607,151
$301.11 P/Share
|
Apr 05
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
113,756
-0.04%
|
$33,444,264
$294.4 P/Share
|
Apr 04
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
39,393
-0.04%
|
$11,542,149
$293.15 P/Share
|
Apr 01
2022
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
165,376
-0.08%
|
$48,289,792
$292.7 P/Share
|